Wellinghoff Darryl 4
4 · LA JOLLA PHARMACEUTICAL CO · Filed Feb 19, 2020
Insider Transaction Report
Form 4
Wellinghoff Darryl
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-02-14+229→ 229 totalExercise: $8.40Exp: 2030-02-14→ Common Stock (229 underlying) - Award
Common Stock
2020-02-14$7.14/sh+229$1,635→ 8,244 total
Footnotes (2)
- [F1]These shares were acquired on 02/14/2020 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- [F2]The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years.